contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


capital-increase-in-monsenso-as-as-a-result-of-warrants-exercised-by-employees-2

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Monsenso operates in the IT sector. The company specializes in the provision of digital follow-up systems for care and nursing, as well as hospitals. The solutions are software-based and are mainly used for monitoring patients' health, as well as for internal monitoring and analysis. The largest operations are in the Nordic market. The head office is located in Copenhagen.

Monsenso

31.3.2025 11:54:06 CEST | Monsenso | Company AnnouncementCompany announcement no. 04-2025Frederiksberg, 2025.03.31Monsenso A/S announced today that the Company´s share capital had been increased...

31.3.2025 11:54:06 CEST | Monsenso | Company AnnouncementCompany announcement no. 04-2025Frederiksberg, 2025.03.31Monsenso A/S announced today that the Company´s share capital had been increased by nominally DKK 13,332.00 due to the exercise of warrant programs.The capital increase is subscribed in cash at a price per share of DKK 0.22, without pre-emptive rights for the company's existing shareholders or others. Proceeds for the company amount to DKK 29,330.00. The capital increase corresponds to 0.20 % of the company's previous share capital.The new shares are ordinary, without special rights and freely transferable negotiable&nbsp;instruments. The new shares are entitled to dividends and other rights in the company from the time of registration of the capital increase. The new shares will be admitted to listing on Nasdaq First North Growth Market Denmark as soon as possible after registration with the Danish Business Authority.Monsenso's current share capital amounts to a nominal DKK 6,664,018.20 divided into 66,640,182 shares of DKK 0.10. The capital increase is expected to be completed soon, and after registration the following is expected:<table class="prs-table"><tbody><tr><td>Nominal value of shares DKK</td><td class="prs-align--right">6,677,350.20</td></tr><tr><td>The volume of shares (nom. DKK 0.10)</td><td class="prs-align--right">66,773,502</td></tr></tbody></table>Any inquiries regarding this notice should be directed to:MonsensoCEO Thomas Lethenborg Tel +45 21 29 88 27 E-mail:&nbsp;<a href="mailto:lethenborg@monsenso.com">lethenborg@monsenso.com</a>&nbsp;Chairman of the board Peter Mørch Eriksen E-mail:&nbsp;<a href="mailto:eriksen@monsenso.com">eriksen@monsenso.com</a>Certified Adviser:HC Andersen Capital Bredgade 23, 1260 København K<h4>About Monsenso</h4>Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit <a href="http://www.monsenso.com">www.monsenso.com</a><h4>Attachments</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13559904/14334020/15305/Download%20announcement%20as%20PDF.pdf">Download announcement as PDF.pdf</a> </li></ul>

Capital increase in Monsenso A/S as a result of warrants exercised by employees

About Monsenso

Attachments

Privacy preferences

Nominal value of shares DKK	6,677,350.20
The volume of shares (nom. DKK 0.10)	66,773,502